Israel’s IceCure says gets FDA nod to treat tumors in liver, kidney

Published 6y ago

JERUSALEM (Reuters) – Israel’s IceCure Medical said on Sunday it received U.S. regulatory approval to expand the use of its cryoablation technology to treat benign and cancerous tumors in livers and kidneys, sending its share price up 30%. IceCure’s treatment ... More »